Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Teladoc Health Inc.

    NYSE: TDOC · Real-Time Price · USD
    7.03
    0.17 (2.48%)
    At close: Jun 16, 2025, 3:59 PM
    6.95
    -1.14%
    Pre-market: Jun 17, 2025, 05:21 AM EDT

    Teladoc Health Statistics

    Share Statistics

    Teladoc Health has 175.44M shares outstanding. The number of shares has increased by 2.41% in one year.

    Shares Outstanding

    n/a
    		 175.44M

    Shares Change (YoY)

    n/a
    		 2.41%

    Shares Change (QoQ)

    n/a
    		 0.87%

    Owned by Institutions (%)

    n/a
    		 75.05%

    Shares Floating

    n/a
    		 173.47M

    Failed to Deliver (FTD) Shares

    n/a
    		 381

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 23.05M, so 13.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 23.05M

    Short % of Shares Out

    n/a
    		 13.27%

    Short % of Float

    n/a
    		 17.17%

    Short Ratio (days to cover)

    n/a
    		 5.03

    Valuation Ratios

    The PE ratio is -1.55 and the forward PE ratio is -7.71. Teladoc Health's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.55

    Forward PE

    n/a
    		 -7.71

    PS Ratio

    n/a
    		 0.6

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 1.04

    P/FCF Ratio

    n/a
    		 5.48

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Teladoc Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.

    Current Ratio

    n/a
    		 1.77

    Quick Ratio

    n/a
    		 1.73

    Debt / Equity

    n/a
    		 1.06

    Debt / EBITDA

    n/a
    		 -2.7

    Debt / FCF

    n/a
    		 5.6

    Interest Coverage

    n/a
    		 -42.89

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $556,184.85

    Profits Per Employee

    n/a
    		 $-216,719.7

    Employee Count

    n/a
    		 4,620

    Asset Turnover

    n/a
    		 0.73

    Inventory Turnover

    n/a
    		 19.7

    Taxes

    Income Tax

    n/a
    		 7.59M

    Effective Tax Rate

    n/a
    		 -0.76%

    Stock Price Statistics

    The stock price has increased by -30.46% in the last 52 weeks. The beta is 1.78, so Teladoc Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.78

    52-Week Price Change

    n/a
    		 -30.46%

    50-Day Moving Average

    n/a
    		 7.13

    200-Day Moving Average

    n/a
    		 8.95

    Relative Strength Index (RSI)

    n/a
    		 46.51

    Average Volume (20 Days)

    n/a
    		 5,244,149

    Income Statement

    In the last 12 months, Teladoc Health had revenue of 2.57B and earned -1B in profits. Earnings per share was -5.87.

    Revenue

    n/a
    		 2.57B

    Gross Profit

    n/a
    		 1.82B

    Operating Income

    n/a
    		 -1.02B

    Net Income

    n/a
    		 -1B

    EBITDA

    n/a
    		 -587.01M

    EBIT

    n/a
    		 -969.85M

    Earnings Per Share (EPS)

    n/a
    		 -5.87
    Full Income Statement

    Balance Sheet

    The company has 1.3B in cash and 1.58B in debt, giving a net cash position of -286.29M.

    Cash & Cash Equivalents

    n/a
    		 1.3B

    Total Debt

    n/a
    		 1.58B

    Net Cash

    n/a
    		 -286.29M

    Retained Earnings

    n/a
    		 -16.23B

    Total Assets

    n/a
    		 3.44B

    Working Capital

    n/a
    		 649.41M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 293.68M and capital expenditures -10.79M, giving a free cash flow of 282.89M.

    Operating Cash Flow

    n/a
    		 293.68M

    Capital Expenditures

    n/a
    		 -10.79M

    Free Cash Flow

    n/a
    		 282.89M

    FCF Per Share

    n/a
    		 1.66
    Full Cash Flow Statement

    Margins

    Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.

    Gross Margin

    n/a
    		 70.76%

    Operating Margin

    n/a
    		 -39.73%

    Pretax Margin

    n/a
    		 -38.67%

    Profit Margin

    n/a
    		 -38.97%

    EBITDA Margin

    n/a
    		 -22.84%

    EBIT Margin

    n/a
    		 -39.73%

    FCF Margin

    n/a
    		 11.01%

    Dividends & Yields

    TDOC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TDOC is $9, which is 28% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 28%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 19
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.26

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist